Shock therapy for migraines? wearable device shows promise in prevention

NCT ID NCT07487701

Completed Disease control Sponsor: Theranica Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 02, 2026 · Updated 3 times

Summary

This study tested a wearable device called Nerivio that delivers mild electrical pulses to the arm to help prevent migraines. 150 people with chronic migraine used the device for 3 months. Researchers tracked changes in monthly migraine days, attack duration, and patient-reported improvement. The goal is to see if this non-drug approach can reduce migraine frequency and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nerivio REN device (a wearable that sends mild electrical pulses to the arm to help prevent migraines)
What this could lead to: If it works, this could offer a drug-free option to reduce migraine frequency and improve quality of life for people with chronic migraine.
What could go wrong: This is a small, single-group real-world study without a placebo control, so results may be less reliable. The device may not work for everyone, and long-term effects are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE HEADACHE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

headache disorder migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MIGRAINE HEADACHE MIGRAINE

Contacts and locations

Locations

Theranica Bio-Electronics Inc

Bridgewater, New Jersey, 08807, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.